SCOPUS 정보 검색 플랫폼

Toxicologic Pathology

Volumn 40, Issue 7, 2012, Pages 1079-1081

Regulatory forum opinion piece: Thresholds in toxicologic pathology

(2) Long, Gerald G a Hardisty, Jerry F b

a Experimental Pathology Laboratories (United States)

b EXPERIMENTAL PATHOLOGY LABORATORIES INC (United States)

Author keywords

histopathologic lesions; morphology; threshold

Indexed keywords

ARTICLE; CARCINOGENICITY; CLINICAL PRACTICE; HISTOPATHOLOGY; HUMAN; LABORATORY; LIVER CELL; MICROSCOPY; MORPHOLOGY; NONHUMAN; PATHOGENESIS; PATHOLOGIST; PRIORITY JOURNAL; TOXICOLOGY;

ANIMALS; ANIMALS, LABORATORY; DOSE-RESPONSE RELATIONSHIP, DRUG; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PATHOLOGY; REFERENCE VALUES; RISK ASSESSMENT; TOXICOLOGY; XENOBIOTICS;

EID: 84867094889 PISSN: 01926233 EISSN: 15331601 Source Type: Journal
DOI: 10.1177/0192623312443322 Document Type: Article

Times cited : (16)

References (9)

1
- 82355169071
- Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies
- Burkhardt J. E., Pandher K., Solter P. F., Troth S. P., Boyce R. W., Zabka T. S., Ennulat D.. Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies. Toxicol Pathol. 2011 ; 39: 1129-37
- (2011) Toxicol Pathol , vol.39 , pp. 1129-1137
- Burkhardt, J.E.¹ Pandher, K.² Solter, P.F.³ Troth, S.P.⁴ Boyce, R.W.⁵ Zabka, T.S.⁶ Ennulat, D.⁷

2
- 1342302718
- Best practices guideline: Toxicologic histopathology
- Crissman J. W., Goodman D. G., Hildebrandt P. K., Maronpot R. R., Prater D. A., Riley J. H., Seaman W. J., Thake D. C.. Best practices guideline: Toxicologic histopathology. Toxicol Pathol. 2004 ; 32: 126-31
- (2004) Toxicol Pathol , vol.32 , pp. 126-131
- Crissman, J.W.¹ Goodman, D.G.² Hildebrandt, P.K.³ Maronpot, R.R.⁴ Prater, D.A.⁵ Riley, J.H.⁶ Seaman, W.J.⁷ Thake, D.C.⁸

3
- 22244437297
- The comparative power of the discriminant methods used in toxicological pathology
- Holland T.. The comparative power of the discriminant methods used in toxicological pathology. Toxicol Pathol. 2005 ; 33: 490-94
- (2005) Toxicol Pathol , vol.33 , pp. 490-494
- Holland, T.¹

4
- 79959468880
- Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe to treatment?)
- Holland T., Holland C.. Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe to treatment?). Toxicol Pathol. 2011a ; 39: 569-75
- (2011) Toxicol Pathol , vol.39 , pp. 569-575
- Holland, T.¹ Holland, C.²

5
- 82355175354
- Response to letter to editor by Dr. J. C. Wolf on "analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe to treatment?)."
- Holland T., Holland C.. Response to letter to editor by Dr. J. C. Wolf on "Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe to treatment?).". Toxicol Pathol. 2011b ; 39: 1138
- (2011) Toxicol Pathol , vol.39 , pp. 1138
- Holland, T.¹ Holland, C.²

6
- 80053613354
- Sponsor-CRO practices that facilitate the creation of a high-quality pathology report: A pharmaceutical sponsor's perspective
- Irizarry Rovira A. R., Foley G. L., Clemo F. A.. Sponsor-CRO practices that facilitate the creation of a high-quality pathology report: A pharmaceutical sponsor's perspective. Toxicol Pathol. 2011 ; 39: 1013-16
- (2011) Toxicol Pathol , vol.39 , pp. 1013-1016
- Irizarry Rovira, A.R.¹ Foley, G.L.² Clemo, F.A.³

7
- 82355172657
- Concerning the analysis of unbiased histopathology data
- Levin S.. Concerning the analysis of unbiased histopathology data. Toxicol Pathol. 2011 ; 39: 1139
- (2011) Toxicol Pathol , vol.39 , pp. 1139
- Levin, S.¹

8
- 80053606541
- Counterpoint to "analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe to treatment?)."
- Wolf J. C.. Counterpoint to "Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe to treatment?).". Toxicol Pathol. 2011 ; 39: 1017-19
- (2011) Toxicol Pathol , vol.39 , pp. 1017-1019
- Wolf, J.C.¹

9
- 84867084071
- Berlin, Heidelberg, New York: Springer-Verlag;
- Zbinden G. Progress in Toxicology, vol. 2. Berlin, Heidelberg, New York: Springer-Verlag ; 1976: 8-18.
- (1976) Progress in Toxicology, Vol. 2 , pp. 8-18
- Zbinden, G.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.